Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor backend/version update and does not change the study information or how the page is used.
    Difference
    0.0%
    Check dated 2026-08-11T18:36:02.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Site revision updated from v3.6.3 to v3.6.4, signaling a platform update rather than any modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T12:36:17.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Publications section added with a PubMed-derived citation and a note about automatic population from PubMed. The change provides direct literature references and clarifies data provenance for the study record.
    Difference
    0.2%
    Check dated 2026-07-14T08:51:22.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3. This is a minor version update and does not affect the study content or page functionality.
    Difference
    0.0%
    Check dated 2026-07-07T01:01:34.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.0 to v3.6.2, indicating a maintenance update to the ClinicalTrials.gov entry. This change does not modify study content or results.
    Difference
    0.0%
    Check dated 2026-06-29T18:47:06.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    New navigation/help sections were added to help users find joining information, contact details, how to read a study record, common questions, and how to join a study. The 'Intervention / Treatment' label was normalized to 'Intervention/Treatment' and the revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T09:42:02.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.